Johnson & Johnson and GlaxoSmithKline are leading research into new antibiotics - but a new report has called for further action to combat the rise of drug-resistant bacteria.<
Sanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, after serious safety concerns halted its use.
The FDA has approved an HIV dual therapy developed by GSK’s specialist joint venture, ViiV Healthcare, a convenient combination that will compete with Gilead's nearly-approved three-drug re
